Zai Lab (ZLAB) Competitors $25.78 -0.45 (-1.72%) (As of 11:30 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ZLAB vs. RVMD, QGEN, ITCI, ROIV, ASND, LEGN, ELAN, BPMC, LNTH, and NUVLShould you be buying Zai Lab stock or one of its competitors? The main competitors of Zai Lab include Revolution Medicines (RVMD), Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Elanco Animal Health (ELAN), Blueprint Medicines (BPMC), Lantheus (LNTH), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Zai Lab vs. Revolution Medicines Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Legend Biotech Elanco Animal Health Blueprint Medicines Lantheus Nuvalent Zai Lab (NASDAQ:ZLAB) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, community ranking, risk, earnings, media sentiment, institutional ownership and dividends. Do analysts prefer ZLAB or RVMD? Zai Lab currently has a consensus target price of $52.50, suggesting a potential upside of 103.65%. Revolution Medicines has a consensus target price of $61.00, suggesting a potential upside of 5.45%. Given Zai Lab's higher possible upside, research analysts clearly believe Zai Lab is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zai Lab 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 3.08 Does the MarketBeat Community prefer ZLAB or RVMD? Zai Lab received 141 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 74.56% of users gave Revolution Medicines an outperform vote while only 64.20% of users gave Zai Lab an outperform vote. CompanyUnderperformOutperformZai LabOutperform Votes22664.20% Underperform Votes12635.80% Revolution MedicinesOutperform Votes8574.56% Underperform Votes2925.44% Which has more risk & volatility, ZLAB or RVMD? Zai Lab has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Is ZLAB or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to Zai Lab's net margin of -76.14%. Revolution Medicines' return on equity of -33.67% beat Zai Lab's return on equity.Company Net Margins Return on Equity Return on Assets Zai Lab-76.14% -36.97% -27.10% Revolution Medicines N/A -33.67%-30.08% Which has higher valuation and earnings, ZLAB or RVMD? Zai Lab has higher revenue and earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than Zai Lab, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZai Lab$266.72M9.63-$334.62M-$2.77-9.31Revolution Medicines$11.58M840.37-$436.37M-$3.59-16.11 Does the media favor ZLAB or RVMD? In the previous week, Zai Lab had 15 more articles in the media than Revolution Medicines. MarketBeat recorded 20 mentions for Zai Lab and 5 mentions for Revolution Medicines. Zai Lab's average media sentiment score of 0.62 beat Revolution Medicines' score of -0.05 indicating that Zai Lab is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zai Lab 4 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in ZLAB or RVMD? 41.7% of Zai Lab shares are owned by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are owned by institutional investors. 13.9% of Zai Lab shares are owned by company insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryZai Lab beats Revolution Medicines on 10 of the 19 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZLAB vs. The Competition Export to ExcelMetricZai LabPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.57B$6.48B$5.08B$8.80BDividend YieldN/A8.11%5.02%4.07%P/E Ratio-9.314.9791.2813.60Price / Sales9.63371.451,226.2187.40Price / CashN/A52.5939.4536.27Price / Book3.8510.306.906.33Net Income-$334.62M$153.61M$118.83M$225.93M7 Day Performance-3.34%-1.73%-1.92%-0.96%1 Month Performance-7.93%-7.26%-3.75%1.06%1 Year Performance-5.98%31.10%31.37%26.59% Zai Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZLABZai Lab2.9675 of 5 stars$25.78-1.7%$52.50+103.6%-7.2%$2.57B$266.72M-9.312,175Analyst RevisionRVMDRevolution Medicines2.7998 of 5 stars$57.85+1.4%$61.00+5.4%+162.6%$9.73B$11.58M0.00443QGENQiagen4.2716 of 5 stars$42.070.0%$50.88+20.9%+2.5%$9.60B$1.97B107.975,967Positive NewsITCIIntra-Cellular Therapies4.4737 of 5 stars$84.86-0.9%$97.23+14.6%+46.2%$9.00B$464.37M-98.44560Positive NewsROIVRoivant Sciences3.1207 of 5 stars$11.82+2.9%$17.93+51.7%+30.6%$8.74B$124.79M2.09860ASNDAscendis Pharma A/S3.0193 of 5 stars$124.05-0.3%$191.77+54.6%+32.7%$7.52B$288.08M0.00640Analyst UpgradeLEGNLegend Biotech1.7671 of 5 stars$39.86-0.7%$81.46+104.4%-33.7%$7.27B$285.14M0.001,800Analyst RevisionELANElanco Animal Health4.1237 of 5 stars$13.43-0.1%$17.14+27.6%+13.1%$6.64B$4.42B33.609,300BPMCBlueprint Medicines2.7179 of 5 stars$95.59+0.8%$122.11+27.7%+43.9%$6.07B$249.38M0.00640Analyst ForecastAnalyst RevisionLNTHLantheus4.5969 of 5 stars$87.29+1.0%$122.50+40.3%+25.1%$6.07B$1.30B14.38834Positive NewsNUVLNuvalent2.1777 of 5 stars$93.07+2.1%$112.60+21.0%+51.1%$6.03BN/A0.0040 Related Companies and Tools Related Companies Revolution Medicines Alternatives Qiagen Alternatives Intra-Cellular Therapies Alternatives Roivant Sciences Alternatives Ascendis Pharma A/S Alternatives Legend Biotech Alternatives Elanco Animal Health Alternatives Blueprint Medicines Alternatives Lantheus Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZLAB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZLAB Stock Alerts